Hotel Liability Slip and Fall: Spinal Injury, Surgery, and Pharmacy Lien Documentation

James Wong — Founder & Pharmacist, LienScripts | February 16, 2026 | 9 min read

A hotel guest slipped on a wet lobby floor and sustained an L5-S1 disc herniation requiring microdiscectomy surgery. After employer-sponsored health insurance denied injury-related care, a pharmacy lien covered the medication gap — from pre-op preparation through 14 months of post-surgical management — creating a continuous documentation record that supported a strong premises liability settlement.

Hotel Liability Slip and Fall: Spinal Injury, Surgery, and Pharmacy Lien Documentation

Note: This is a fictionalized case study based on composite facts. Names and identifying details are not real. The clinical details represent typical medication patterns for this injury type.

Premises liability cases against hotels and large commercial properties carry unique dynamics that pure auto accident cases do not. The defendant is typically a well-insured corporate entity with experienced in-house risk management and defense counsel who specialize in minimizing slip-and-fall claims. The defense playbook is predictable: argue that the condition was open and obvious, that the plaintiff contributed to their own fall, and that any injuries were pre-existing or degenerative rather than traumatic. Against this backdrop, the quality of the plaintiff's medical and pharmaceutical documentation becomes a decisive factor.

This case study examines how a 14-month pharmacy lien record — covering a surgical spinal injury from a hotel lobby fall — built the evidentiary foundation for a strong premises liability settlement.

Case Background

Patient: Sandra K. (name changed), 52-year-old female, regional sales director Incident: Sandra was a guest at a large downtown hotel during a three-day professional conference. Returning from a breakfast meeting, she slipped on a wet lobby floor near the hotel restaurant entrance. There was no wet-floor warning sign in place at the time of the fall. Surveillance footage later confirmed the absence of any posted warning. Sandra fell backward and landed hard on her lower back and hip. Emergency Response: Hotel staff called 911. Sandra was transported to a local emergency department where imaging revealed an acute L5-S1 disc herniation with nerve root compression. She was admitted overnight for pain management and imaging review. Insurance Situation: Sandra had employer-sponsored health insurance through her company. However, when her orthopedic spine surgeon's office submitted claims for pre-operative consultation and diagnostic imaging, the insurer flagged the claims as injury-related and invoked its coordination-of-benefits provision, directing the family to pursue the hotel's general liability policy first. The health insurer declined to pay any injury-related claims during active litigation. Attorney: Thomas B. (name changed), a premises liability specialist at a mid-sized plaintiff firm.

Injuries: L5-S1 Disc Herniation with Nerve Root Compression

The L5-S1 herniation Sandra suffered was not a borderline finding. Imaging showed a large central and right paracentral disc herniation with compression of the right S1 nerve root, causing radiculopathy down the right leg — sciatica with numbness and weakness in the foot and calf. Conservative management was attempted for six weeks: physical therapy, anti-inflammatory medications, and epidural steroid injections. The radiculopathy did not resolve.

At eight weeks post-injury, her spine surgeon recommended microdiscectomy — a minimally invasive surgical procedure to remove the herniated disc material compressing the nerve root. Sandra agreed and the surgery was scheduled for week ten.

The defense's predictable early argument was that the L5-S1 findings were "pre-existing degenerative disc disease" rather than a traumatic herniation. Her spine surgeon addressed this directly: while some degree of disc desiccation was visible at adjacent levels — consistent with a 52-year-old's normal aging — the large herniation at L5-S1 with acute nerve root compression was inconsistent with chronic degeneration and highly consistent with a forceful axial load, exactly the mechanism of a backward fall.

The Health Insurance Gap and Pharmacy Lien Coverage

When Thomas confirmed that the health insurer would not pay injury-related claims, he enrolled Sandra in the LienScripts pharmacy lien program at week six — before surgery had been scheduled. This timing was critical: it meant the lien program captured the entire pre-surgical medication period, the perioperative management, and the full post-operative recovery — creating one continuous documentation record rather than a fragmented one.

Medication Timeline

Pre-Operative Phase: Weeks 6-10

Meloxicam 15mg daily was initiated as the primary NSAID for nerve root inflammation during the conservative management trial. The 15mg dose reflected the significant inflammatory component of the nerve root compression.

Gabapentin 300mg three times daily, titrated to 600mg three times daily by week 8, was prescribed for the radicular leg pain and the S1 nerve root pain pattern. Radiculopathy pain — sharp, shooting, burning, and positional — responds poorly to opioids and standard NSAIDs but often responds meaningfully to gabapentinoids. The dose escalation was documented with a clear clinical rationale: partial but insufficient response at 300mg TID.

Diazepam 5mg at bedtime for muscle spasm associated with the acute herniation. The lumbosacral musculature commonly goes into protective spasm in the acute herniation phase, and the low-dose bedtime benzodiazepine addressed both spasm and sleep disruption. The prescription was documented with a time-limited plan — benzodiazepines for acute spasm only, not chronic use.

Cyclobenzaprine 5mg as needed for daytime breakthrough spasm. The combination of bedtime diazepam and PRN daytime cyclobenzaprine was explicitly documented as a short-term acute management protocol.

Perioperative Period: Weeks 10-12

Celecoxib 200mg was substituted for meloxicam in the immediate pre-operative window. The surgeon requested a COX-2 specific inhibitor pre-operatively to reduce surgical site inflammation while minimizing platelet effects. The pharmacy lien record captured this transition seamlessly.

Post-operative prescriptions filled through the lien program included:

• Oxycodone/acetaminophen 5/325mg for the immediate post-surgical pain period (7-day supply with documented plan for taper)
• Methocarbamol 750mg for post-surgical muscle spasm
• Omeprazole 20mg for GI protection during the NSAID management period

The post-surgical opioid was filled for one 7-day course only. The pharmacy record clearly documented the controlled, time-limited nature of the opioid prescribing — an important detail for any case where defense counsel might attempt to characterize the pain management as excessive.

[!KEY] Documenting a short, time-limited opioid course following spinal surgery — with a clear taper plan in the pharmacy record — preempts any defense argument about inappropriate opioid prescribing and demonstrates that the pain management was medically calibrated and responsible.

Post-Operative Months 3-14: Nerve Recovery and Long-Term Management

The surgery was successful in relieving the acute nerve root compression. However, S1 nerve root injuries that have been compressed for weeks prior to decompression frequently leave residual neuropathic symptoms during the nerve's slow regeneration. Sandra experienced persistent right-foot numbness and intermittent radicular pain during the recovery period.

Gabapentin 600mg three times daily was continued post-operatively, with the clinical rationale being ongoing S1 neuropathic symptoms. The decision to continue rather than immediately taper the gabapentin was documented — a point later emphasized by Thomas's expert, who noted that premature tapering in the setting of ongoing neuropathic symptoms is clinically inappropriate and the prescribing decision reflected sound management.

Duloxetine 30mg daily, titrated to 60mg daily at month 5, was added for persistent neuropathic pain and the significant depression that had developed in the context of a prolonged recovery that was threatening Sandra's professional performance. Duloxetine has a dual indication: neuropathic pain and depression. The pharmacy record captured the titration and the clinical notes explaining the dual indication.

Cyclobenzaprine 5mg as needed continued through month 8 for episodic lumbar muscle spasm during progressive rehabilitation.

By month 10, Sandra had returned to modified duty. By month 14, she was working full-time. Her gabapentin was being tapered gradually with close monitoring for recurrent radicular symptoms.

[!KEY] A 14-month pharmacy record showing continuous treatment from pre-operative through full post-surgical recovery creates an unbroken clinical timeline that demonstrates both the severity of the injury and the sustained medical necessity of the treatment — a timeline the defense cannot reframe as "sporadic" or "inconsistent with the claimed severity."

Documentation Value

The MERIT report generated by LienScripts at case resolution documented 14 months of continuous pharmaceutical management across multiple medication categories:

• NSAIDs and COX-2 inhibitors (entire pre-operative and early post-operative period)
• Gabapentinoid therapy (continuous from week 6 through month 14)
• Short-term muscle relaxants (pre- and post-operative, appropriately time-limited)
• Brief post-surgical opioid course (7 days, well-documented taper plan)
• Duloxetine for combined neuropathic pain and post-injury depression (month 4 onward)
• Proton pump inhibitor for GI protection throughout NSAID course

This organized pharmaceutical timeline served three functions in the litigation:

Refuting the pre-existing degenerative condition argument. The defense argued that Sandra's disc disease was pre-existing. The pharmacy record showed no prescription pain medications of any kind in Sandra's history prior to the fall — she had no prior NSAID prescriptions, no prior gabapentin, no prior muscle relaxants. The lien enrollment date was six weeks post-accident. There was no pre-accident pharmaceutical record to suggest a chronic pain condition.

Establishing causation through treatment necessity. The clinical escalation from NSAIDs to gabapentinoids to surgery to post-operative dual neuropathic/antidepressant management was not the trajectory of a minor soft-tissue injury. It was the trajectory of a significant, surgical nerve injury. The medication record told that story independently of any single physician's testimony.

Supporting future medical cost projections. Sandra's physiatrist opined that gabapentin or an equivalent agent would likely be required for an additional 12 to 18 months post-settlement to manage the ongoing S1 neuropathic symptoms. The 14-month documentation record provided the continuous treatment history needed to credibly project that forward cost.

Settlement Outcome

The case settled after a full-day mediation session. The hotel's insurer initially offered a figure that Thomas described as "soft-tissue money" — an amount appropriate for a strain that resolved in a few months, not a surgical spinal injury with residual neuropathy. The mediator walked defense counsel through the MERIT report and the pharmacy lien timeline in detail.

The final settlement reflected surgical medical bills, the pharmacy lien balance, future pharmaceutical costs, lost wages, and substantial non-economic damages for the pain, the surgery, and the extended recovery that had disrupted Sandra's professional life for over a year.

Key Takeaways for Premises Liability Attorneys

Hotel and commercial property defendants have experienced risk management teams whose job is to minimize every claim. The best counter is a clinical record that is too detailed, too continuous, and too medically complex to be dismissed. When your client's health insurer refuses to cover injury-related care — a common scenario in premises liability cases — a pharmacy lien fills the coverage gap and simultaneously generates the documentation record. The two benefits are inseparable.

Enroll early. Pre-operative pharmacy documentation is as important as post-operative documentation. If the entire treatment arc is captured under a single lien, the timeline is seamless — and seamless timelines are credible timelines.

Related Resources

• Slip and Fall Injury Medications: What to Expect
• Herniated Disc Medications and Pharmacy Lien
• Gabapentin vs. Pregabalin for Personal Injury
• Health Insurance Subrogation vs. Pharmacy Lien
• Pharmacy Lien Support for Ambulatory Surgery Centers